We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

551:HKEXYue Yuen Industrial (Holdings) Limited Analysis

Data as of 2026-03-16 - not real-time

NT$15.80

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at TWD 15.8, just above the identified support of TWD 15.1 and well below the resistance of TWD 16.7. Technicals show a bearish alignment with the 20‑day SMA (15.84) below the 50‑day SMA (16.10) and the 200‑day SMA (17.17), confirming downward momentum. The RSI sits at 45.5, indicating neutral momentum without clear over‑bought or over‑sold conditions. Despite the bearish backdrop, the MACD histogram turned positive and the MACD signal is flagged as bullish, hinting at a possible short‑term reversal. Volume has been trending downwards, and today’s volume (4,103) is far below the 10‑day average of 34,617, raising concerns about liquidity. The 30‑day volatility of 14.5% and a low beta of 0.31 suggest modest price swings relative to the market but limited downside protection.
Fundamentally, the company is in distress, with revenue plunging by nearly 100% year‑over‑year and operating margins deep in the negative (-15%). EBITDA and operating cash flow are both strongly negative, and the balance sheet is leveraged, reflected by a debt‑to‑equity ratio of 73% and total debt of TWD 2.27 billion. Cash reserves of TWD 134 million are insufficient to offset the debt burden, and free cash flow remains heavily negative. The price‑to‑book ratio of 1.22 places the market price only slightly above book value, while the price‑to‑sales ratio exceeds 600, underscoring the earnings weakness. No dividend is paid, eliminating any income component for investors. The Fear & Greed Index at 72.9 (“Greed”) indicates a market bias toward risk‑on sentiment, but the company’s financial profile remains fundamentally weak.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish SMA alignment
  • Current price near support
  • Low liquidity

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt and negative cash flow
  • Potential MACD‑driven bounce
  • Valuation close to book value

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental turnaround required
  • Industry cyclicality
  • Low beta limits systematic risk

Key Metrics & Analysis

Financial Health

Revenue Growth-99.80%
ROE-0.96%
ROA-0.61%
Debt/Equity72.82
P/B Ratio1.2
Op. Cash FlowNT$-818558016
Free Cash FlowNT$-850168128
Industry P/E32.5

Technical Analysis

TrendBearish
RSI45.5
SupportNT$15.10
ResistanceNT$16.70
MA 20NT$15.84
MA 50NT$16.10
MA 200NT$17.17
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.31
Volatility14.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.